一、产品概述
N-(2,6-二氟苯基)-5-[3-[2-[[5-乙基-2-甲氧基-4-[4-[4-(甲基磺酰基)-1-哌嗪基]-1-哌啶基]苯基]氨基]-4-嘧啶基]咪唑并[1,2-A]吡啶-2-基]-2-甲氧基苯甲酰胺 是来自Absin品牌的高品质产品,适用于科研实验领域。
更多产品描述请查看优宁维旗下爱必信官网(https://www.absin.cn/gsk1904529a/abs813203.html?mk_channel=chemicalbook)
二、产品信息
| 货号 | abs813203 |
| SKU货号 | abs813203-5mg |
| 品牌 | Absin |
| 中文名称 | N-(2,6-二氟苯基)-5-[3-[2-[[5-乙基-2-甲氧基-4-[4-[4-(甲基磺酰基)-1-哌嗪基]-1-哌啶基]苯基]氨基]-4-嘧啶基]咪唑并[1,2-A]吡啶-2-基]-2-甲氧基苯甲酰胺 |
| 英文名称 | GSK1904529A |
| CAS号 | 1089283-49-7 |
| 纯度 | >98% |
| 分子量 | 851.96 |
| 可溶性 | DMSO :114 mg/mL (133.8 mM) |
| 抗原名称 | Insulin Receptor ,IGF-1R |
商品描述
GSK1904529A是一种选择性的IGF-1R和IR抑制剂,IC50分别为27 nM和25 nM,作用于IGF-1R/InsR比作用于Akt1/2/, Aurora A/B,B-Raf, CDK2, EGFR等选择性高100倍以上。GSK1904529A 是选择性抑制剂,作用于IGF-IR和IR时IC50分别为27和25 nM。GSK1904529A是可逆的ATP竞争性抑制剂。GSK1904529A 作用于IGF-IR和IR时Ki值分别为1.3和1.6 nM。
In vitro(体外研究)
GSK1904529A is a reversible, ATP-competitive inhibitor and has enzyme-inhibitor binding values against IGF-1R and IR with Ki of 1.6 nM and 1.3 nM, respectively. GSK1904529A potently inhibits the ligand-induced phosphorylation of IGF-1R and IR at concentrations above 0.01 μM, followed by blocking downstream signaling (AKT, IRS-1, and ERK). GSK1904529A potently inhibits NIH-3T3/LISN, TC-71, SK-N-MC, SK-ES RD-ES cells with IC50 of 60 nM, 35 nM, 43 nM, 61 nM and 62 nM, respectively. GSK1904529A also inhibits other multiple myeloma and Ewing's sarcoma cell lines including NCI-H929, MOLP-8, LP-1 and KMS-12-BM etc. GSK1904529A induces cell cycle arrest at the G1 phase in cell lines COLO 205, MCF-7, and NCI-H929, which are sensitive to GK1904529A.
In vivo(体内研究)
GSK1904529A indicates 98% tumor growth inhibition in NIH-3T3/LISN tumor-bearing mice at a dose of 30 mg/kg (orally, twice-daily) and 75% in COLO 205 xenografts mice (once daily). Among HT29 and BxPC3 xenografts, GSK1904529A produces moderate tumor growth inhibition with no side effects at a dose of 30 mg/kg. Meanwhile, GSK1904529A shows minimal effects on blood glucose levels. GSK1904529A (~3.5 μM in blood) completely inhibits IGF-1R phosphorylation. GSK1904529A has been implicated in treatment of various IGF-1R-dependent tumors including prostate, colon, breast, pancreatic, ovarian, and sarcomas.
三、背景
四、制备和贮存
| 保存方式 | Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution. |
五、产品特点
- 品质保证:经过严格的质量控制,确保产品的高品质和稳定性。
- 高纯度:纯度达到<p>>98%</p>。
六、注意事项
- 本产品仅供科学研究使用,不可用于临床诊断或治疗。
- 请在通风良好的环境下操作,佩戴适当的个人防护装备。
- 如不慎接触皮肤或眼睛,请立即用大量清水冲洗并就医。